Business Description
Imagion Biosystems Ltd
NAICS : 621511
SIC : 8099
ISIN : AU000000IBX6
Compare
Compare
Traded in other countries / regions
IBX.AustraliaIBXXF.USA IPO Date
2017-06-22Description
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | -10.08 | |||||
| Debt-to-Equity | -0.61 | |||||
| Debt-to-EBITDA | -0.77 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -30.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 70 | |||||
| 3-Year EBITDA Growth Rate | -12.1 | |||||
| 3-Year EPS without NRI Growth Rate | -15.3 | |||||
| 3-Year FCF Growth Rate | -4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.67 | |||||
| 9-Day RSI | 28.51 | |||||
| 14-Day RSI | 32.36 | |||||
| 6-1 Month Momentum % | -58.82 | |||||
| 12-1 Month Momentum % | -89.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.09 | |||||
| Quick Ratio | 0.09 | |||||
| Cash Ratio | 0.07 | |||||
| Days Sales Outstanding | 18.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 | |||||
| Shareholder Yield % | 0.34 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -505.81 | |||||
| Net Margin % | -336.96 | |||||
| FCF Margin % | -139.73 | |||||
| ROE % | -2939.26 | |||||
| ROA % | -175.91 | |||||
| ROIC % | -154.62 | |||||
| ROC (Joel Greenblatt) % | -179.86 | |||||
| ROCE % | -329.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.32 | |||||
| EV-to-EBIT | -1.29 | |||||
| EV-to-EBITDA | -1.6 | |||||
| EV-to-Revenue | 3.54 | |||||
| EV-to-FCF | -2.53 | |||||
| Earnings Yield (Greenblatt) % | -77.52 | |||||
| FCF Yield % | -68.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Imagion Biosystems Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1.875 | ||
| EPS (TTM) (A$) | -0.184 | ||
| Beta | 0.54 | ||
| Volatility % | 95.92 | ||
| 14-Day RSI | 32.36 | ||
| 14-Day ATR (A$) | 0.004035 | ||
| 20-Day SMA (A$) | 0.0322 | ||
| 12-1 Month Momentum % | -89.71 | ||
| 52-Week Range (A$) | 0.018 - 0.365 | ||
| Shares Outstanding (Mil) | 201.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Imagion Biosystems Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Imagion Biosystems Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Imagion Biosystems Ltd Frequently Asked Questions
What is Imagion Biosystems Ltd(ASX:IBX)'s stock price today?
The current price of ASX:IBX is A$0.02. The 52 week high of ASX:IBX is A$0.37 and 52 week low is A$0.02.
When is next earnings date of Imagion Biosystems Ltd(ASX:IBX)?
The next earnings date of Imagion Biosystems Ltd(ASX:IBX) is 2025-01-31 Est..
Does Imagion Biosystems Ltd(ASX:IBX) pay dividends? If so, how much?
Imagion Biosystems Ltd(ASX:IBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers